240 related articles for article (PubMed ID: 26220772)
1. Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease.
Aguilo F; Di Cecilia S; Walsh MJ
Curr Top Microbiol Immunol; 2016; 394():29-39. PubMed ID: 26220772
[TBL] [Abstract][Full Text] [Related]
2. High Positive Correlations between
Drak Alsibai K; Vacher S; Meseure D; Nicolas A; Lae M; Schnitzler A; Chemlali W; Cros J; Longchampt E; Cacheux W; Pignot G; Callens C; Pasmant E; Allory Y; Bieche I
Noncoding RNA; 2019 Aug; 5(3):. PubMed ID: 31438464
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis.
Chi JS; Li JZ; Jia JJ; Zhang T; Liu XM; Yi L
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):816-822. PubMed ID: 29270737
[TBL] [Abstract][Full Text] [Related]
4. ANRIL inhibits p15(INK4b) through the TGFβ1 signaling pathway in human esophageal squamous cell carcinoma.
Chen D; Zhang Z; Mao C; Zhou Y; Yu L; Yin Y; Wu S; Mou X; Zhu Y
Cell Immunol; 2014; 289(1-2):91-6. PubMed ID: 24747824
[TBL] [Abstract][Full Text] [Related]
5. ANRIL regulates production of extracellular matrix proteins and vasoactive factors in diabetic complications.
Thomas AA; Feng B; Chakrabarti S
Am J Physiol Endocrinol Metab; 2018 Mar; 314(3):E191-E200. PubMed ID: 29118015
[TBL] [Abstract][Full Text] [Related]
6. ANRIL and atherosclerosis.
Chen L; Qu H; Guo M; Zhang Y; Cui Y; Yang Q; Bai R; Shi D
J Clin Pharm Ther; 2020 Apr; 45(2):240-248. PubMed ID: 31703157
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA
Lou N; Liu G; Pan Y
Future Oncol; 2020 Dec; 16(35):2981-2995. PubMed ID: 32986472
[TBL] [Abstract][Full Text] [Related]
8. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
9. Truncated Isoforms of lncRNA ANRIL Are Overexpressed in Bladder Cancer, But Do Not Contribute to Repression of INK4 Tumor Suppressors.
Hoffmann MJ; Dehn J; Droop J; Niegisch G; Niedworok C; Szarvas T; Schulz WA
Noncoding RNA; 2015 Dec; 1(3):266-284. PubMed ID: 29861427
[TBL] [Abstract][Full Text] [Related]
10. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1.
Pasmant E; Sabbagh A; Masliah-Planchon J; Ortonne N; Laurendeau I; Melin L; Ferkal S; Hernandez L; Leroy K; Valeyrie-Allanore L; Parfait B; Vidaud D; Bièche I; Lantieri L; Wolkenstein P; Vidaud M;
J Natl Cancer Inst; 2011 Nov; 103(22):1713-22. PubMed ID: 22034633
[TBL] [Abstract][Full Text] [Related]
11. Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value.
Meseure D; Vacher S; Alsibai KD; Nicolas A; Chemlali W; Caly M; Lidereau R; Pasmant E; Callens C; Bieche I
Mol Cancer Res; 2016 Jul; 14(7):623-33. PubMed ID: 27102007
[TBL] [Abstract][Full Text] [Related]
12. Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks.
Holdt LM; Hoffmann S; Sass K; Langenberger D; Scholz M; Krohn K; Finstermeier K; Stahringer A; Wilfert W; Beutner F; Gielen S; Schuler G; Gäbel G; Bergert H; Bechmann I; Stadler PF; Thiery J; Teupser D
PLoS Genet; 2013; 9(7):e1003588. PubMed ID: 23861667
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression.
Yu Y; Chen Q; Zhang X; Yang J; Lin K; Ji C; Xu A; Yang L; Miao L
Cancer Sci; 2020 Jul; 111(7):2297-2309. PubMed ID: 32378752
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA
Cho H; Shen GQ; Wang X; Wang F; Archacki S; Li Y; Yu G; Chakrabarti S; Chen Q; Wang QK
J Biol Chem; 2019 Mar; 294(11):3881-3898. PubMed ID: 30655286
[TBL] [Abstract][Full Text] [Related]
15. The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: An in vivo and in vitro study.
Chen S; Zhang JQ; Chen JZ; Chen HX; Qiu FN; Yan ML; Chen YL; Peng CH; Tian YF; Wang YD
Int J Biol Macromol; 2017 Sep; 102():718-728. PubMed ID: 28344092
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA
Holdt LM; Teupser D
Front Cardiovasc Med; 2018; 5():145. PubMed ID: 30460243
[TBL] [Abstract][Full Text] [Related]
17. CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC.
Congrains A; Kamide K; Katsuya T; Yasuda O; Oguro R; Yamamoto K; Ohishi M; Rakugi H
Biochem Biophys Res Commun; 2012 Mar; 419(4):612-6. PubMed ID: 22382030
[TBL] [Abstract][Full Text] [Related]
18. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS.
Pasmant E; Sabbagh A; Vidaud M; Bièche I
FASEB J; 2011 Feb; 25(2):444-8. PubMed ID: 20956613
[TBL] [Abstract][Full Text] [Related]
19. ANRIL/CDKN2B-AS shows two-stage clade-specific evolution and becomes conserved after transposon insertions in simians.
He S; Gu W; Li Y; Zhu H
BMC Evol Biol; 2013 Nov; 13():247. PubMed ID: 24225082
[TBL] [Abstract][Full Text] [Related]
20. ANRIL regulates the proliferation of human colorectal cancer cells in both two- and three-dimensional culture.
Naemura M; Tsunoda T; Inoue Y; Okamoto H; Shirasawa S; Kotake Y
Mol Cell Biochem; 2016 Jan; 412(1-2):141-6. PubMed ID: 26708220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
